Academic literature on the topic 'Signes neurologiques'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Signes neurologiques.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Signes neurologiques":
Nuss, Ph, F. Ferreri, C. Agbokou, and C. S. Peretti. "Signes neurologiques dans la schizophrénie." L'Encéphale 33, no. 3 (June 2007): S392—S394. http://dx.doi.org/10.1016/s0013-7006(07)74588-8.
Fongoro, S., APC SAMIZA, H. Yattara, S. SY, D. Diallo, M. Coulibaly, and M. Samake. "Abcès cérébral chez une patiente hémodialysée chronique." Revue Malienne d'Infectiologie et de Microbiologie 15, no. 2 (November 27, 2020): 4–7. http://dx.doi.org/10.53597/remim.v15i2.1723.
Bourgou Gaha, S., S. Halayem Dhouib, I. Amado, and A. Bouden. "Signes neurologiques mineurs dans la schizophrénie précoce." L'Encéphale 41, no. 3 (June 2015): 209–14. http://dx.doi.org/10.1016/j.encep.2014.01.005.
Halayem, S., A. Bouden, M. B. Halayem, K. Tabbane, I. Amado, and M. O. Krebs. "Signes neurologiques mineurs et troubles envahissants du développement." L'Encéphale 36, no. 4 (September 2010): 307–13. http://dx.doi.org/10.1016/j.encep.2009.12.012.
Belrose, C., E. Rakotoarison, L. Boyer, and M. Trousselard. "Signes neurologiques mineurs et TSPT : un marqueur de sévérité ?" French Journal of Psychiatry 1 (November 2018): S138. http://dx.doi.org/10.1016/s2590-2415(19)30364-2.
Krebs, M. O., and S. Mouchet. "Signes neurologiques mineurs et schizophrénie : revue des données actuelles." Revue Neurologique 163, no. 12 (December 2007): 1157–68. http://dx.doi.org/10.1016/s0035-3787(07)78400-x.
Mechri, Anwar, Héla Slama, Sabeur Chebel, Olfa Mandhouj, and Lotfi Gaha. "Traitement neuroleptique et signes neurologiques mineurs chez les patients schizophrènes." Therapies 62, no. 5 (September 2007): 449–53. http://dx.doi.org/10.2515/therapie:2007066.
Sabatier, J., S. Boetto, M. Gigaud, F. Roux, E. Schmidt, and M. Tremoulet. "Fractures de l’odontoïde avec signes neurologiques : étude rétrospective depuis 1996." Neurochirurgie 50, no. 5 (November 2004): 589. http://dx.doi.org/10.1016/s0028-3770(04)98392-0.
Froment-Ernouf, P., and P. Aboukrat. "La tendinopathie d’Achille dans la xanthomatose cérébrotendineuse : à propos d’un cas." Médecine et Chirurgie du Pied 36, no. 3 (September 2020): 75–81. http://dx.doi.org/10.3166/mcp-2020-0056.
Froment-Ernouf, P., and P. Aboukrat. "La tendinopathie d’Achille dans la xanthomatose cérébrotendineuse : à propos d’un cas." Médecine et Chirurgie du Pied 36, no. 3 (September 2020): 75–81. http://dx.doi.org/10.3166/mcp-2020-0056.
Dissertations / Theses on the topic "Signes neurologiques":
Mouchet-Mages, Sabine. "Corrélats structuraux des anomalies neurologiques mineures dans la schizophrénie." Paris 6, 2008. http://www.theses.fr/2008PA066345.
Gourion, David. "Stratégie phénotype-génotype dans le contexte de l'hypothèse développementale de la schizophrenie." Paris 6, 2004. http://www.theses.fr/2004PA066140.
Ferreri, Florian. "Marqueurs diagnostiques et pronostiques dans la schizophrénie : intérêt des signes neurologiques mineurs et des marqueurs lipidiques membranaires." Paris 6, 2012. http://www.theses.fr/2012PA066328.
Picard, Hernan J. "Signes neurologiques mineurs et saccades oculaires dans la schizophrénie : corrélats physiopathologiques et arguments pour une implication du cervelet." Paris 6, 2010. http://www.theses.fr/2010PA066507.
The cognitive dysmetria hypothesis of schizophrenia proposes that dysfunctions of the cortico-cerebellar-thalamo-cortical circuits (CCTC), neurodevelopmental in origin, would be the basis of the disease. We evaluated at the behavioral level, the CCTC circuits in schizophrenia, through saccadic eye tests and Neurological Soft Signs (NSS). Firstly, we studied the correlations between NSS scores and three saccadic paradigms (simple, predictive and memorized saccades) in a group of schizophrenic patients (n = 78) vs a healthy control group (n = 41) the hypothesis being that NSS scores would be correlated with saccadic abnormalities. Subsequently, we compared patients with schizophrenia (n = 23) vs healthy controls (n = 13) in a saccadic adaptation paradigm, which is very sensitive to dysfunction of the cerebellum. NSS allowed us to define more homogeneous subgroups of subjects with a high "developmental load" (SZNSS+) or a low "developmental load" (SZNSS-). Compared with controls, SZNSS+ (n = 12) had slower and incomplete saccadic adaptation, especially in its initial phase, suggesting a probable involvement of the cerebellum in the physiopathology of the disease. The overall results are discussed in light of the cognitive dysmetria hypothesis and current knowledge on the physiology of the cerebellum and eye movements. This work also highlights the importance of intermediate phenotypes (including NSS) in basic research in psychiatry
SIMON, JOSE. "Contribution a l'etude des traumatismes du rachis dorsal et lombaire sans signes neurologiques, etude multicentrique : a propos de 191 cas." Rennes 1, 1992. http://www.theses.fr/1992REN1M071.
Dervaux, Alain. "Influence de la consommation de substances sur l’émergence et l’évolution des troubles psychotiques : le cas du cannabis." Paris 6, 2010. https://tel.archives-ouvertes.fr/tel-00814790.
The higher prevalence of cannabis abuse or dependence in patients at high risk of schizophrenia, in patients with first psychotic episode, and during the course of schizophrenia patients with schizophrenia, compared with general population is well established. The reasons remain unclear and include familial vulnerability to drug use disorders, psychotomimetic effects induced by cannabis use, or personality traits. We have studied some aspects regarding vulnerability factors to cannabis use disorders in patients with schizophrenia: 1) We found that neurological soft signs scores were significantly higher in patients with cannabis dependence only, compared to healthy subjects, in particular regarding motor coordination and sensory integration 2) We found that the mean scores for impulsivity and sensation seeking were higher in a group of schizophrenia patients with lifetime cannabis abuse or dependence than in a group of schizophrenia patients without cannabis abuse or dependence 3) We assessed the role of individual sensitivity to the psychotogenic effect of cannabis among male patients with schizophrenia, and found that the first psychotic episode occurred 2. 6 years earlier in cannabis-sensitive patients compared to non cannabis-sensitive patients. A specific excess of familial history of psychotic disorder was found in these patients 4) We found that the pattern of substance use disorders found in a group of Moroccan patients with schizophrenia was different from those found in previous studies from North America or Europe, suggesting that substance use disorders could be influenced by socio-cultural context and by the availability of cannabis
Dervaux, Alain. "Influence de la consommation de substances sur l'émergence et l'évolution des troubles psychotiques." Phd thesis, Université Pierre et Marie Curie - Paris VI, 2010. http://tel.archives-ouvertes.fr/tel-00814790.
Gay, Olivier. "Marqueurs neurodéveloppementaux en psychiatrie : intérêt dans les troubles schizophréniques." Thesis, Sorbonne Paris Cité, 2016. http://www.theses.fr/2016USPCB016/document.
The term neurodevelopment in its broadest sense refers to all of the processes encompassing development of the nervous system from the earliest stages of formation in utero to later stages of maturation during adolescence to produce the fully functional adult nervous system. Work over the last thirty years has led to a neurodevelopmental model of human psychiatric disorders, including schizophrenia, based on genetic, epidemiological and imaging evidence. This model asserts that disease is fundamentally linked to or develops from abnormality(s) in the formation processes (early neurodevelopment) and maturation (late neurodevelopment) of the nervous system due to a combination of genetic and environmental factors. In this context this thesis aims to clarify the effects of neurodevelopmental abnormalities on psychiatric disorders, including schizophrenia, through the study of different markers. The first study aims to investigate correlations between markers of early brain development: a clinical marker (neurological soft signs) and an imaging marker (sulcation of the cerebral cortex) in a population of subjects with schizophrenia. A correlation between these two markers is presented: the sulcation index was found to be lower in subjects that had significant neurological soft signs. We concluded that the combined study of different markers may help to isolate subgroups of patients with greater early neurodevelopmental damage. The second study aims to characterize effects of different markers of early neurodevelopmental abnormalities on cognitive functioning in patients with schizophrenia. Effects on executive control (as measured by the Trail Making Test) were correlated with clinical markers (neurological soft signs, handedness) and imaging (sulcation of the anterior cingulate cortex and enlargment of the ventricles). We found interactions between different markers with a mainly non-linear summation effect. Our interpretation is that different markers reflect separate insults, though all early, on brain development with a common final effect on executive function. The third study aims to clarify the specificity of sulcation as a marker of early neurodevelopmental abnormalities by studying a population of adult subjects with autism spectrum disorder (ASD), a patholody beginning in early childhood and linked with evidence of early neurodevelopmental damage. Sulcation abnormalities of the anterior cingulate cortex, similar to those observed in patients with schizophrenia are detected in patients with ASD. These results suggest early neurodevelopmental abnormalities are shared by different psychiatric disorders and that changes in cortical sulcation are not specific to a given disorder but the early damage. In conclusion, we suggest that the study of neurodevelopmental abnormalities should be integrated into a dimensional approach in psychiatry
Jaafari, Nematollah. "Un TOC ou des TOC ? : apport clinique et thérapeutique à la compréhension de la psychobiologie du trouble obsessionnel compulsif." Poitiers, 2012. http://www.theses.fr/2012POIT1409.
Obsessive-compulsive disorder (OCD) as a homogeneous disease is characterized by obsessions (which cause marked anxiety or distress) and/or by compulsions (which serve to neutralize anxiety). The essential features of OCD are recurrent obsessions or compulsions that are severe enough to be time consuming (i. E they take more than 1 hour a day) or cause marked distress or significant impairment or significantly interfere with the individual’s normal routine, occupation functioning, or usual social activities or relationships with others. At some point during the course of the disorder, the person realizes that the obsessions or compulsions are excessive or unreasonable. The treatment of OCD involves a combination of psychotherapy (such as cognitivebehavioral) and pharmacological therapies (serotonergic antidepressants and neuroleptics and / or mood stabilizers). A proportion of patients (40-60%) remain symptomatic despite wellconducted treatment, and some have a form so severe that it leads to major disability and represents a public health issue. For the treatment of these resistant patients, deep brain stimulation, adaptable and reversible technique, and rTMS transcranial magnetic stimulation (rTMS) offers the opportunity for a novel therapeutic approach, based on the pathophysiology of the disease, and to selectively modulate relatively dysfunctional cortico-striato-pallidothalamo-cortical, limbic and associative, neural networks involved in the genesis of symptoms. These therapeutic techniques are effective but 10 to 20% of patients do not respond to these treatments. Our hypothesis is that, probably, OCD is a heterogeneous disease and some clinical forms do not respond to treatment. To test this hypothesis, we chose two factors: Neurological soft signs (NSS) and insight. Using the definition of OCD as a homogeneous disease, we found that NSS do occur in OCD, but without any correlation with therapeutic response. Using a heterogeneous definition of OCD, we demonstrated that patients with poor insight showed more checking behaviour and had more memory déficits. Future research will be necessary with an OCD definition as a heterogeneous disease
Duclos, Céline. "Vulnérabilité neurodéveloppementale et évolution de la schizophrénie." Paris 6, 2005. http://www.theses.fr/2005PA066401.
Books on the topic "Signes neurologiques":
J, Walsh Thomas. Neuro-ophthalmology: Clinical signs and symptoms. 2nd ed. Philadelphia: Lea & Febiger, 1985.
(Editor), T. Kumazawa, L. Kruger (Editor), and K. Mizumura (Editor), eds. The Polymodal Receptor - A Gateway to Pathological Pain (Progress in Brain Research). Elsevier Science, 1996.
Takao, Kumazawa, Kruger Lawrence, and Mizumura Kazue, eds. The polymodal receptor: A gateway to pathological pain. Amsterdam: Elsevier, 1996.
Book chapters on the topic "Signes neurologiques":
Servant, Marie-Laure, Adeline Marionneau, and Jean-Michel Albaret. "Signes neurologiques doux." In Manuel d'enseignement de psychomotricité, 30–42. De Boeck Supérieur, 2018. http://dx.doi.org/10.3917/dbu.albar.2017.01.0030.
Fuller, Geraint, and Catherine Masson. "Signes spéciaux." In L'Examen Neurologique Facile, 177–82. Elsevier, 2009. http://dx.doi.org/10.1016/b978-2-8101-0115-3.00025-1.